Bli medlem
Bli medlem

Du är här


Actelion Pharmaceuticals Ltd: Actelion to discuss nine month 2015 financial results

Actelion Pharmaceuticals Ltd / Actelion to discuss nine month 2015 financial
results. Processed and transmitted by NASDAQ OMX Corporate Solutions. The
issuer is solely responsible for the content of this announcement.
Dear member of the investment community

Actelion Ltd will announce its first nine month 2015 financial results on
Tuesday, 20 October 2015, at 07:00hrs CEST / 06:00hrs BST / 1:00 a.m. EDT.

An investor conference call&webcast will be held at 14:00hrs, CEST to discuss
the results.

To support your preparations, consensus estimates can be found


| |
| 20 October 2015 14:00hrs - 14:45hrs Basel (CEST) |
| 13:00hrs - 13:45hrs UK (BST) |
| 8:00 a.m. - 8:45 a.m. US (EDT) |

Conference Call Connect #:

Dial-in participants should start calling the number below 10-15 minutes
before the conference is due to start.

| |
| Dial: Europe: +41 (0)44 583 18 01 |
| UK: +44 203 009 24 60 |
| US: +1 855 228 38 74 |
Participant's mode:

Listen-Only with possibility to open individual lines during Q&A session.
Participants will be asked for their Name and Company.

Webcast Access

Webcast participants should visit the Actelion websitewww.actelion.com10-15
minutes before the conference is due to start.

Participant's mode: Listen-Only

Webcast Replay:

The archived Investor Webcast will be available for replay
throughwww.actelion.comapproximately 60 minutes after the call has ended.

Invitation PDF


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.